Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer. Lacouture ME, Goldfarb SB, Markova A, Chawla SP, et al. Breast Cancer Res Treat 2022 Apr 26. pii: 10.1007/s10549-022-06584.

Read + Share

Amedeo Smart

Independent Medical Education

Lacouture ME, Goldfarb SB, Markova A, Chawla SP, et al. Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer. Breast Cancer Res Treat 2022 Apr 26. pii: 10.1007/s10549-022-06584.
PMID: 35471470